Cargando…
Development of an Ingestible Expandable Capsule for Weight Loss
Obesity has grown to epidemic proportions with 2.1 billion people being overweight worldwide. A food-grade expandable capsule named EndoXpand for the treatment of overweight people was designed and developed in this study. EndoXpand consists of an inner expandable material (core), an embracing membr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779746/ https://www.ncbi.nlm.nih.gov/pubmed/36554702 http://dx.doi.org/10.3390/ijerph192416821 |
_version_ | 1784856685163053056 |
---|---|
author | Liu, Xingyu Wu, Yeung Liu, Chang Chen, Kaiqi Gregersen, Hans |
author_facet | Liu, Xingyu Wu, Yeung Liu, Chang Chen, Kaiqi Gregersen, Hans |
author_sort | Liu, Xingyu |
collection | PubMed |
description | Obesity has grown to epidemic proportions with 2.1 billion people being overweight worldwide. A food-grade expandable capsule named EndoXpand for the treatment of overweight people was designed and developed in this study. EndoXpand consists of an inner expandable material (core), an embracing membrane, and a gelatin capsule shell. It is designed to occupy volume in the stomach and reduce hunger sensation. The occupied volume is changeable over time, dependent on the number of ingested capsules and their degradation time. This will avoid gastric accommodation to constant volume devices as seen in the use of intragastric balloons. Several materials were tested. Collagen casing was selected as the membrane and corn silk was used to tie the membrane. Dried black fungus (Auricularia auricula) was the biological material that expanded most. However, synthesized cellulose-based hydrogel expanded more and was chosen as the optimal expandable core material. The hydrogel-based EndoXpand expanded 72 times after soaking in an acidic environment for 80 min. The corn silk ligations weakened and broke after 3 h. This resulted in release of the expanded material that was designed to easily pass the pylorus and travel down the intestine for digestion or excretion. In conclusion, this study provides design and in vitro proof-of-technology data for a potential groundbreaking approach. Further studies are needed in animal models and human phase I studies. |
format | Online Article Text |
id | pubmed-9779746 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97797462022-12-23 Development of an Ingestible Expandable Capsule for Weight Loss Liu, Xingyu Wu, Yeung Liu, Chang Chen, Kaiqi Gregersen, Hans Int J Environ Res Public Health Article Obesity has grown to epidemic proportions with 2.1 billion people being overweight worldwide. A food-grade expandable capsule named EndoXpand for the treatment of overweight people was designed and developed in this study. EndoXpand consists of an inner expandable material (core), an embracing membrane, and a gelatin capsule shell. It is designed to occupy volume in the stomach and reduce hunger sensation. The occupied volume is changeable over time, dependent on the number of ingested capsules and their degradation time. This will avoid gastric accommodation to constant volume devices as seen in the use of intragastric balloons. Several materials were tested. Collagen casing was selected as the membrane and corn silk was used to tie the membrane. Dried black fungus (Auricularia auricula) was the biological material that expanded most. However, synthesized cellulose-based hydrogel expanded more and was chosen as the optimal expandable core material. The hydrogel-based EndoXpand expanded 72 times after soaking in an acidic environment for 80 min. The corn silk ligations weakened and broke after 3 h. This resulted in release of the expanded material that was designed to easily pass the pylorus and travel down the intestine for digestion or excretion. In conclusion, this study provides design and in vitro proof-of-technology data for a potential groundbreaking approach. Further studies are needed in animal models and human phase I studies. MDPI 2022-12-15 /pmc/articles/PMC9779746/ /pubmed/36554702 http://dx.doi.org/10.3390/ijerph192416821 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Liu, Xingyu Wu, Yeung Liu, Chang Chen, Kaiqi Gregersen, Hans Development of an Ingestible Expandable Capsule for Weight Loss |
title | Development of an Ingestible Expandable Capsule for Weight Loss |
title_full | Development of an Ingestible Expandable Capsule for Weight Loss |
title_fullStr | Development of an Ingestible Expandable Capsule for Weight Loss |
title_full_unstemmed | Development of an Ingestible Expandable Capsule for Weight Loss |
title_short | Development of an Ingestible Expandable Capsule for Weight Loss |
title_sort | development of an ingestible expandable capsule for weight loss |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779746/ https://www.ncbi.nlm.nih.gov/pubmed/36554702 http://dx.doi.org/10.3390/ijerph192416821 |
work_keys_str_mv | AT liuxingyu developmentofaningestibleexpandablecapsuleforweightloss AT wuyeung developmentofaningestibleexpandablecapsuleforweightloss AT liuchang developmentofaningestibleexpandablecapsuleforweightloss AT chenkaiqi developmentofaningestibleexpandablecapsuleforweightloss AT gregersenhans developmentofaningestibleexpandablecapsuleforweightloss |